Skip to main navigation Skip to search Skip to main content
Manmeet Ahluwalia

View Scopus Profile

Manmeet Ahluwalia

Deputy Director, Chief Medical Oncology and Chief Scientific Officer

    Personal profile

    About

    Manmeet Ahluwalia, M.D., FACP, M.B.A., is the chief of solid tumor medical oncology, deputy director and chief scientific officer at Miami Cancer Institute. As a neuro-oncologist, Dr. Ahluwalia’s primary areas of research and patient care are primary tumors and brain metastases. He joined Miami Cancer Institute from the Cleveland Clinic, where he was the Dean and Diane Miller Family Endowed Chair in Neuro-Oncology and the Head of Operations in the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center (BBTC). He also served as a professor in the Department of Medicine at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University.
     
    Dr. Ahluwalia helped develop a world-class clinical trials program for brain tumors at the Cleveland Clinic. These trials involved immunotherapy and precision medicine-based approaches to target genetic alterations that drive disease. His research has been published in over 175 peer-reviewed publications, including the JAMA, JAMA Oncology, Neuro-Oncology, Journal of Clinical Oncology, Clinical Cancer Research, Cancer Discovery, Nature Reviews Neurology, Nature Reviews and Nature Reviews Clinical Oncology. In 2016, he was selected to participate in the American Society of Clinical Oncology’s Leadership Development Program. This prestigious year-long program allowed Dr. Ahluwalia to work with the top leaders in oncology from all over the world. He and his colleagues designed research for patients, caregivers and other oncologists to help them advance the field of oncology. As part of this program, he also met with members of Congress on Capitol Hill to promote funding for cancer research.

    Dr. Ahluwalia is fluent in English, Hindi and Punjabi.  In addition to his medical degree, Dr. Ahluwalia holds a Master of Business Administration from Case Western Reserve and the Cleveland Clinic.

    Related documents

    Education/Academic qualification

    M.B.A., Business Administration (Healthcare track), Case Western Reserve University

    2018 → 2020

    Fellowship Program - Hematology Oncology, Roswell Park Center Institute

    2006 → 2009

    Cleveland Clinic Health System, Residency Program - Internal Medicine, Fairview Hospital

    2003 → 2006

    Department of Pathobiology & Laboratory Medicine, Research Fellowship, University of Toronto

    2002 → 2003

    Maulana Azad Medical College, Medicine & Surgery, M.B.B.S., University of Delhi

    1995 → 2000

    Senior, Secondary Examination, Delhi Public School

    1993 → 1995

    External positions

    Program Director, Neuro-Oncology Fellowship, Cleveland Clinic , Cleveland, Ohio

    Jan 1 2017 → Jan 1 2020

    Head of Operations, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic , Cleveland, Ohio

    Jan 1 2015 → Jan 1 2020

    Director, brain metastasis research program, brain tumor and neuro-oncology center, Cleveland Clinic, Cleveland, Ohio

    Jan 1 2014 → Jan 1 2020

    Associate Director Clinical Trials, Operations, brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio

    Jan 1 2013 → Jan 1 2020

    Section Head , Neuro-Oncology Outcomes, Brain Tumors and Neuro-Oncology Center, Cleveland Clinic , Cleveland, Ohio

    Jan 1 2009 → Jan 1 2020

    Disciplines

    • Medicine and Health Sciences
    • Neurology
    • Oncology
    View all 20 projects
    View all 955 Research outputs
    • 4 Membership of network
    View all 12 prizes
    View all 7 courses